Vanguard Group Inc Pds Biotechnology Corp Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Vanguard Group Inc holds 1,951,343 shares of PDSB stock, worth $2.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,951,343

Previous 1,510,221 29.21%

Holding current value

$2.4 Million

Previous $1.8 Million 44.41%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$0.94 - $1.79 $414,654 - $789,608	441,122 Added 29.21%	1,951,343 $2.6 Million
Q1 2025 May 09, 2025	BUY	$1.18 - $1.8 $5,202 - $7,936	4,409 Added 0.29%	1,510,221 $1.8 Million
Q4 2024 Feb 11, 2025	SELL	$1.63 - $4.11 $25,641 - $64,654	-15,731 Reduced 1.03%	1,505,812 $2.45 Million
Q3 2024 Nov 13, 2024	BUY	$2.93 - $4.23 $330,222 - $476,737	112,704 Added 8.0%	1,521,543 $5.81 Million
Q2 2024 Aug 13, 2024	SELL	$2.55 - $4.02 $456,365 - $719,447	-178,967 Reduced 11.27%	1,408,839 $4.13 Million
Q1 2024 May 10, 2024	BUY	$3.85 - $6.59 $316,219 - $541,269	82,135 Added 5.46%	1,587,806 $6.29 Million
Q4 2023 Feb 14, 2024	SELL	$3.95 - $6.58 $7,979 - $13,291	-2,020 Reduced 0.13%	1,505,671 $7.48 Million
Q3 2023 Nov 14, 2023	SELL	$4.8 - $6.4 $563,788 - $751,718	-117,456 Reduced 7.23%	1,507,691 $7.61 Million
Q2 2023 Aug 14, 2023	BUY	$5.03 - $9.9 $1.64 Million - $3.23 Million	326,672 Added 25.16%	1,625,147 $8.17 Million
Q1 2023 May 15, 2023	BUY	$5.68 - $11.99 $777,876 - $1.64 Million	136,950 Added 11.79%	1,298,475 $7.99 Million
Q4 2022 Feb 10, 2023	BUY	$3.28 - $13.2 $44,106 - $177,500	13,447 Added 1.17%	1,161,525 $15.3 Million
Q3 2022 Nov 14, 2022	BUY	$2.97 - $5.79 $160,953 - $313,777	54,193 Added 4.95%	1,148,078 $3.41 Million
Q1 2022 May 13, 2022	BUY	$4.78 - $8.43 $377,739 - $666,180	79,025 Added 7.79%	1,093,885 $6.77 Million
Q4 2021 Feb 14, 2022	BUY	$7.76 - $14.35 $288,346 - $533,217	37,158 Added 3.8%	1,014,860 $8.22 Million
Q3 2021 Nov 12, 2021	BUY	$9.33 - $17.08 $132,486 - $242,535	14,200 Added 1.47%	977,702 $14.6 Million
Q2 2021 Aug 13, 2021	BUY	$4.35 - $12.86 $4.19 Million - $12.4 Million	963,502 New	963,502 $12.1 Million

Others Institutions Holding PDSB

# of Institutions

Shares Held

7.38M

Call Options Held

98.2K

Put Options Held

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $35M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Pds Biotechnology Corp Transaction History